Loading clinical trials...

Geographic Analysis of Cancer Patients' Residences at Delafontaine Hospital | Clinical Trials | Clareo Health

NOT_YET_RECRUITING

Geographic Analysis of Cancer Patients' Residences at Delafontaine Hospital

NCT07206914•Centre Hospitalier de Saint-Denis

Summary

This study looks at where cancer patients treated at Delafontaine Hospital live and how far they have to travel for care. By mapping patients' home addresses (anonymized), the research will show how distance, transportation, and social factors affect access to cancer treatments and support services. The goal is to better understand inequalities in access to care and to improve patient support in the future.

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•\- Adult patients treated for cancer in the oncology department of Delafontaine Hospital since January 1, 2020.

Exclusion Criteria

•\- Patients whose cancer treatment in the oncology department was completed before 2020.

Locations (1)

Centre Hospitalier de Saint-Denis

Saint-Denis, France, France

Key Dates

Start Date

October 15, 2025

Primary Completion Date

April 15, 2026

Completion Date

April 15, 2026

Last Updated

October 3, 2025

Enrollment

300

ESTIMATED participants

Conditions

NeoplasmsOncology ServiceHealth Services AccessibilityHealth InequalitiesResidence CharacteristicsTransportation of Patients

Post-operative Medium Chain Triglyceride Diet May Reduce Hospital Stay Following Lung Resection

NCT07159659

Thoracic Neoplasms

View study

RECRUITINGPHASE2

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

NCT07169851

NauseaVomiting+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 3, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Geographic Analysis of Cancer Patients' Residences at Delafontaine Hospital

Inclusion Criteria

Exclusion Criteria

Post-operative Medium Chain Triglyceride Diet May Reduce Hospital Stay Following Lung Resection

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease

A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer

Skin Conductance for Predicting Spinal Anesthesia-Induced Hypotension in Geriatric Urologic Oncology Patients

ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies